Indication
Lactating Women
3 clinical trials
5 products
Clinical trial
Evaluation of the Excretion of Viloxazine and Its Metabolite 5-Hydroxy-viloxazine Glucuronide Into Breast Milk Following Multiple Doses of SPN-812 (600mg, QD) in Healthy Lactating WomenStatus: Completed, Estimated PCD: 2023-09-20
Product
SPN-812Product
Bempedoic AcidClinical trial
An Open-Label Postmarking Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid and Ezetimibe in the Breast Milk of Healthy Lactating Women Administered Therapeutic Doses of Bempedoic Acid or Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP)Status: Recruiting, Estimated PCD: 2024-03-01
Product
Bempedoic Acid + EzetimibeClinical trial
Breastfed Child Exposure to Tafenoquine and Primaquine During Treatment in Lactating Women: a Pharmacokinetic Study in Healthy VolunteersStatus: Withdrawn, Estimated PCD: 2025-06-30
Product
PrimaquineProduct
Tafenoquine